Wissenschaftliche Arbeiten

Uzm. Dr. Zekeriya Hannarici

30 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Distinguishing adrenal metastases from benign lesions in NSCLC: the value of clinical and radiological parameters

    BMC cancer, 2026

    DOI 10.1186/s12885-026-15878-7 PMID 41851668 Frei zugänglicher VolltextQuelle: Europe PMC

  2. Comparison of Anthracycline-Containing and Anthracycline-Free Neoadjuvant Regimens in HER2-Positive Breast Cancer

    Research Square, 2026

    DOI 10.21203/rs.3.rs-8673435/v1 Frei zugänglicher VolltextQuelle: OpenAlex

  3. Comparison of anthracycline-containing and anthracycline-free neoadjuvant regimens in HER2-positive breast cancer.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.e13021 Quelle: OpenAlex

  4. Prognostic Value of the Gustave Roussy Immune Score in Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy: A Retrospective Cohort Study

    Diagnostics (Basel, Switzerland), 2026

    DOI 10.3390/diagnostics16121759 PMID 42351419 Frei zugänglicher VolltextQuelle: Europe PMC

  5. Prognostic Value of the Objective Prognostic Score and Palliative Prognostic Index for Short-Term Mortality in Terminal Cancer Patients Receiving Best Supportive Care: A Prospective Observational Single-Center Study

    Journal of clinical medicine, 2026

    DOI 10.3390/jcm15124502 PMID 42355670 Frei zugänglicher VolltextQuelle: Europe PMC

  6. Prognostic Value of Albumin-to-CEA Ratio in Metastatic Colorectal Cancer: A Retrospective Study

    Biomedicines, 2026

    DOI 10.3390/biomedicines14030579 PMID 41898226 Frei zugänglicher VolltextQuelle: Europe PMC

  7. Parameters That May Predict NAC Effectiveness in Hormone-Positive Breast Cancer According to CPS Score

    Cancer Management and Research, 2026

    DOI 10.2147/cmar.s569515 PMID 41859752 Frei zugänglicher VolltextQuelle: OpenAlex

  8. The impact of digital health technology use on oncology-specific clinical guideline adherence among medical oncologists in Turkiye

    Anatolian Current Medical Journal, 2026

    DOI 10.38053/acmj.1943411 Frei zugänglicher VolltextQuelle: OpenAlex

  9. Adjuvant chemotherapy patterns and clinicopathological factors associated with survival in patients aged 70 years and older with resected stage II–III colon cancer: a single-center real-world study

    Journal of Medicine and Palliative Care, 2026

    DOI 10.47582/jompac.1959390 Frei zugänglicher VolltextQuelle: OpenAlex

  10. APPROACH TO METASTATIC ADRENAL MASSES

    Turkiye Klinikleri eBooks, 2026

    DOI 10.5336/978-625-5439-07-9_p141 Quelle: OpenAlex

  11. Prognostic Value of the PILE Score in Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy

    Diagnostics (Basel, Switzerland), 2025

    DOI 10.3390/diagnostics15243158 PMID 41464158 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  12. The Relationship Between Vitamin D and Euthyroid Sick Syndrome in Hospitalized Solid Cancer Patients: A Retrospective Study

    Clinical Medicine Insights Oncology, 2025

    DOI 10.1177/11795549251359147 PMID 40735466 Frei zugänglicher VolltextQuelle: OpenAlex

  13. New Parameters That May Predict Tumor Regression and Survival in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

    Düzce Tıp Fakültesi Dergisi, 2025

    DOI 10.18678/dtfd.1637275 Frei zugänglicher VolltextQuelle: OpenAlex

  14. Survival Comparison and Clinical Characteristics of Sunitinib and Pazopanib in the Treatment of Metastatic Renal Cell Cancer, Single Center Real-Life Data

    Kafkas Journal of Medical Sciences, 2025

    DOI 10.5505/kjms.2025.98250 Frei zugänglicher VolltextQuelle: OpenAlex

  15. Inflammatory parameters in NSCLC with driver mutation

    Lung cancer management, 2024

    DOI 10.2217/lmt-2023-0014 PMID 38818368 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  16. The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker

    Breast Cancer: Targets and Therapy, 2024

    DOI 10.2147/bctt.s464161 PMID 38974895 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  17. A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR)

    BMC Cancer, 2024

    DOI 10.1186/s12885-024-12347-x PMID 38783223 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  18. Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma

    Archives of Basic and Clinical Research, 2024

    DOI 10.5152/abcr.2024.23149 Frei zugänglicher VolltextQuelle: OpenAlex

  19. Bilateral breast metastasis due to rectal cancer: A rare case report

    Open Journal of Clinical and Medical Case Reports, 2024

    DOI 10.52768/2379-1039/2197 Frei zugänglicher VolltextQuelle: OpenAlex

  20. Mide kanserinde adropin ve hipoksi ile indüklenebilir faktör -1 alfa’nın önemi

    Turkish Journal of Clinics and Laboratory, 2024

    DOI 10.18663/tjcl.1442369 Frei zugänglicher VolltextQuelle: OpenAlex

  21. The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer

    Future oncology (London, England), 2023

    DOI 10.2217/fon-2022-0579 PMID 37125596 8 Zitationen (Europe PMC) Quelle: Europe PMC

  22. The clinical significance and diagnostic value of serum Dickkopf1 and CKAP4 levels in patients with gastric cancer: a prospective study.

    PubMed, 2023

    DOI 10.26355/eurrev_202310_34183 PMID 37916373 2 Zitationen (OpenAlex) Quelle: OpenAlex

  23. Evaluation of Clinical and Laboratory Factors Affecting Bone Mineral Density Measurements in Patients with Kidney Transplant

    Journal of Clinical Densitometry, 2022

    DOI 10.1016/j.jocd.2022.01.001 PMID 35168896 Quelle: OpenAlex

  24. Lipegfilgrastim may cause hyperleukocytosis

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022

    DOI 10.1177/10781552221082645 PMID 35200056 1 Zitation (Europe PMC) Quelle: Europe PMC

  25. Reply to John L. Frater’s letter to the editor: Use of laboratory hematology data in melanoma research: comments on ‘A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio’

    Melanoma Research, 2022

    DOI 10.1097/cmr.0000000000000829 PMID 35703446 Quelle: OpenAlex

  26. The Importance of the Glucose-To-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Treated with Sorafenib

    Future Oncology, 2021

    DOI 10.2217/fon-2021-0457 PMID 34431372 18 Zitationen (Europe PMC) Quelle: OpenAlex

  27. Onkolojik Aciller

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.352 Quelle: ORCID

  28. Onkolojide Destek Tedaviler ve Semptom Yönetimi

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.180 Quelle: OpenAlex

  29. A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio

    Melanoma Research, 2021

    DOI 10.1097/cmr.0000000000000785 PMID 34570023 5 Zitationen (OpenAlex) Quelle: OpenAlex

  30. Evaluation of Clinical and Laboratory Parameters Affecting Measurements of Bone Mineral Densitometry in Renal Transplantation Patients

    Endocrinology research and practice., 2018

    DOI 10.25179/tjem.20182202-p110 Frei zugänglicher VolltextQuelle: OpenAlex